{
    "code": "02021862",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021862",
    "time": "2019-05-31 03:17:32",
    "許可證字號": "衛署藥輸字第021862號",
    "註銷狀態": "已註銷",
    "註銷日期": "108\/04\/26",
    "註銷理由": "許可證已逾有效期",
    "有效日期": "106\/08\/20",
    "發證日期": "86\/08\/20",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202186202",
    "中文品名": "&quot;紐蘭&quot; 鹽酸雷尼得定",
    "英文品名": "RANITIDINE HCL",
    "適應症": "Ｈ２受體拮抗劑。",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "主成分略述": [
        "RANITIDINEHCL"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620109C968  新雙隆生技股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "FIN0203200  NEULAND LABORATORIES LIMITED",
        "製造廠廠址": "Unit-Ⅱ, PLOT NO.92-94 &amp; 257-259 IDA, PASHAMYLARAM, ISNAPUR VILLAGE, PATANCHERU MANDAL, SANGAREDDY DISTRICT - 502319, TELANGANA STATE, INDIA",
        "製造廠公司地址": ""
    },
    "CCC號列": "29321920004 鹽酸雷尼得定（雷尼替定）Ranitidine HCL (N-[2[[[5-[( Dimethylamino )methyl]-2-furanyl] methyl]thio]ethyl]N’-methyl-2-nitro-1,1- ethenediamine hydrochloride",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640001210",
            "成分名稱": "RANITIDINE HCL",
            "含量描述": "97.5-102.0",
            "含量": "",
            "單位": "%"
        }
    ]
}